Skip to content

Incidence of Rhinological Morbidities During Endonasal Pituitary Surgery, With or Without Nasoseptal Flap

Incidence of Rhinological Morbidities During Endonasal Pituitary Surgery, With or Without Nasoseptal Flap

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04493801
Acronym
HLNS
Enrollment
160
Registered
2020-07-30
Start date
2019-07-23
Completion date
2022-04-30
Last updated
2020-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery--Complications

Brief summary

Determine and compare prospectively the incidence of rhinological adverse events during pituitary surgery with or without nasoseptal flap

Interventions

None listed

Sponsors

University Hospital, Brest
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* to be over 18 years old * to be operated on for pituitary surgery * to have express no objection to the study

Exclusion criteria

* refusal to participate in the study * pregnant women * to be Under the age of 18 * not being able to understand and accept participation in the study * to have a life expectancy of less than a year

Design outcomes

Primary

MeasureTime frameDescription
post operative epistaxisduring two month after surgeryno epistaxis - begnin epistaxis - severe epistaxis.
post operative rhinoliquorrheaduring two month after surgeryphysical examination and symptomatic rhinorrhea

Countries

France

Contacts

Primary ContactEmmanuel Mornet
emmanuel.mornet@chu-brest.fr330298223004
Backup ContactRomuald seizeur
romuald.seizeur@chu-brest.fr330298342585

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026